Stocks in play: Fennec Pharmaceuticals Inc.
Reported its financial results for the fiscal quarter ended September 30. Net loss for the three months was $8.1 million ($0.31 per share), compared to $4.2 million ($0.16 per share) for the same period in 2021. Fennec Pharmaceuticals Inc. shares T.FRX are trading un at $10.85.
Read:
Highly Sought After Natural Ingredients Appearing in More Plant-Based Products Across North America
Fresher, Healthier Food Options Coming Soon to an Airplane Tray Near You
Airline Industry Wooing Back Customers with Enhanced, Healthier Menu Options
Vegetarian and Vegan Fliers Winning Important Battle Over In-Flight Menu Options
Mega Grocery Store Chains Listening to Customers’ Demands for Nutritious, Clean-Label Foods